IBN and PsychedelicNewsWire to Further Collaborate with Microdose Psychedelic Insights for Upcoming Psychedelic Capital Conference Cannabis Investing News
AbbVie Receives CHMP Positive Opinion for Risankizumab for the Treatment of Adults with Active Psoriatic Arthritis in the European Union Biotech Investing
Sacituzumab Govitecan Receives Positive CHMP Opinion as 2L Treatment for Adult Patients With Metastatic Triple-Negative Breast Cancer Biotech Investing
Pfizer's Abrocitinib Receives Positive CHMP Opinion for the Treatment of Adults with Moderate to Severe Atopic Dermatitis Pharmaceutical Investing
Merck and Eisai Receive Positive EU CHMP Opinions for KEYTRUDA® Plus LENVIMA® in Two Different Types of Cancer Pharmaceutical Investing
Merck Receives Positive CHMP Opinion for VAXNEUVANCE in Individuals 18 Years of Age and Older Pharmaceutical Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Zeposia as a Treatment for Adult Patients with Moderately to Severely Active Ulcerative Colitis Biotech Investing
Johnson & Johnson Ovarian Cancer Victims Vow Fight to Stop J&J's Bankruptcy Scheme Medical Device Investing
Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims Medical Device Investing
Gilead Sciences to Release Third Quarter 2021 Financial Results on Thursday, October 28, 2021 Biotech Investing
